MySTYLE: Online Family-based HIV Prevention for Non-heterosexual Black Adolescent Males in the South
Hiv · Adolescent Behavior · Family Relations · Sexual Orientation
Bottom Line
View on ClinicalTrials.gov: NCT03487796 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MySTYLE (Behavioral); Waitlist Control (Other)
- Age
- Pediatric, Adult · 14+ yrs
- Sex
- All
- Sponsor
- Rhode Island Hospital
- Primary completion
- Apr 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptance of an HIV Test at Study Completion |
8; 8; 9; 10 | — |
| PRIMARY Change in Number of Condomless Anal Sex Acts at 4 Months |
0.7; 0.5 | — |
| SECONDARY HIV Knowledge (Adolescent) at 4 Months |
3.4; 3.5 | — |
| SECONDARY Parent Adolescent Sexual Communication Scale |
20.1; 23.6 | — |
Summary
Eligibility Criteria
Inclusion Criteria
Eligibility criteria for adolescents in all phases of the project will be: 1) at least 14 years of age but no more than 20; 2) stably-housed (have resided with the same adult caregiver for the past 6 months and no plans to leave the city or caregiver in the next 6 months). We understand that this will preclude homeless youth who may be at risk for HIV but MySTYLE will not be designed to address the numerous structural need of chronically homeless youth; 3) the ability to read and speak English; 4) identify as a biological male; 5) and identify racially as Black African American.
Eligibility criteria for Parents/caregivers for all phases of the project will be: 1) parent/caregiver or trusted adult of an adolescent who is potentially eligible for enrollment into the study; and 2) English speaking.
-
Exclusion Criteria: Exclusion criteria will be: a) not able to provide meaningful assent as determined by research staff, b) known HIV-infection (staff will facilitate entry into care if needed). Although we expect that most enrolled youth with be non-heterosexual Black adolescent males, heterosexual youth who enroll will be able to complete all intervention activities.
-
Data sourced from ClinicalTrials.gov (NCT03487796). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.